Pediatric asthma intervention program in New Haven
Community Health Equity Accelerator (CHEA): Community-Academic Asthma Partnership, Pediatric Asthma Intervention
This study is testing a new program in New Haven that helps children with asthma by connecting families to community support and resources for better care and education.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 50 (estimated) |
| Ages | 4 Years to 11 Years |
| Sex | All |
| Sponsor | Yale University Academic / other |
| Locations | 1 site (New Haven, Connecticut) |
| Trial ID | NCT06507943 on ClinicalTrials.gov |
What this trial studies
This pilot initiative aims to establish a partnership between academic and community organizations to implement a multi-level intervention for children with asthma. It includes an online decision support tool and a Promotora program that offers culturally sensitive asthma support alongside legal and medical services. Pediatricians and specialists in New Haven will use a newly developed clinical pathway to refer families to Promotora home visits, which will be conducted either in-person or virtually. The program focuses on improving access to asthma care and enhancing asthma-related outcomes through tailored support and education.
Who should consider this trial
Good fit: Ideal candidates for this program are children diagnosed with asthma who have experienced recent exacerbations or have specific concerns related to asthma management.
Not a fit: Patients living outside of the New Haven area will not benefit from this program.
Why it matters
Potential benefit: If successful, this program could significantly improve asthma management and outcomes for children in the New Haven area.
How similar studies have performed: Other studies have shown success with community health worker interventions in managing chronic conditions, suggesting a promising approach for this initiative.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: Children with a diagnosis of asthma with at least one of the following: * Oral steroid prescription in past 12m * ED visit for asthma in past 12m * Hospital admission for asthma in past 12m * Asthma control test (ACT) score at visit ≤19 * Concern for asthmogenic exposure in the home (such as mold, pests, smoking, or pollution) * At least one missed follow-up appointment for asthma * At least one asthma exacerbation in the prior year * Interested in asthma education (such as education in how to prevent asthma or how to administer medications) * Concern for medication non-adherence Exclusion Criteria: * Living outside of New Haven Zip Code
Where this trial is running
New Haven, Connecticut
- Yale — New Haven, Connecticut, United States (Recruiting)
Study contacts
- Principal investigator: Julia Rosenberg, MD MHS — Yale University
- Study coordinator: Julia Rosenberg, MD MHS
- Email: julia.rosenberg@yale.edu
- Phone: 203-688-2475
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.